An Assessment of the Effect of Human Herpesvirus-6 Replication on Active Cytomegalovirus Infection after Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 5, 2010, Pages 653-661

  Tormo, Nuria ^a   Solano, Carlos ^a,b   de la Cámara, Rafael ^c   Garcia Noblejas, Ana ^c   Cardeñoso, Laura ^c   Clari, María Ángeles ^a   Nieto, José ^d   López, Javier ^e   Hernández Boluda, Juan Carlos ^a   Remigia, María José ^a   Benet, Isabel ^a   Navarro, David ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d HOSPITAL MORALES MESEGUER   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Allo SCT recipient; CMV immune response; CMV replication; Cytomegalovirus (CMV); Human herpesvirus 6 (HHV 6); Interaction

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS DNAEMIA; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GRAFT RECIPIENT; HLA MATCHING; HUMAN; HUMAN HERPESVIRUS 6; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; VIRUS REACTIVATION; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; ROSEOLOVIRUS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION; VIRUS REPLICATION; YOUNG ADULT;

EID: 77951203961     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.12.003     Document Type: Article

References (35)

1. Boechk M., Nichols W.G., Papanicolaou G., Rubin R., Wingard J.R., Zaia J. Cytomegalovirus in hematopoietic transplant recipients: current status, known challenges and future strategies. Biol Blood Marrow Transplant 2003, 9:543-558.
2. de Patger P.J., Schuurman R., Meijer E., van Baarle D., Sanders E.A.M., Boelens J.J. Human herpesvirus type 6 reactivation after hematopoietic stem cell transplantation. J Clin Virol 2008, 43:361-366.
3. Lusso P. HHV-6 and the immune system: mechanisms of immunomodulation and viral scape. J Clin Virol 2006, 37(Suppl 1):S4-S10.
4. DesJardin J.A., Cho E., Supran S., Gibbons L., Werner B.G., Snydman D.R. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. Clin Infect Dis 2001, 33:1358-1362.
5. DesJardin J.A., Gibbons L., Cho E., et al. Human herpesvirus reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J Infect Dis 1998, 178:1783-1786.
6. Dockrell D.H., Prada J., Jones M.F., et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 1997, 176:1135-1140.
7. Humar A., Kumar D., Caliendo A.M., et al. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation 2002, 73:599-604.
8. Humar A., Kumar D., Raboud J., et al. Interactions between cytomegalovirus, human herpesvirus 6 and the recurrence of hepatitis C after liver transplantation. Am J Transplant 2002, 2:461-466.
9. Humar A., Malkan G., Moussa G., Greig P., Levy G., Mazzulli T. Human herpesvirus 6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis 2000, 181:1450-1453.
10. Wang F.-Z., Larsson K., Linde A., Ljungman P. Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2002, 30:521-526.
11. Zerr D.M., Corey L., Kim H.W., Huang M.-L., Nguy L., Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005, 40:932-940.
12. Solano C., Muñoz I., Gutiérrez A., et al. Qualitative plasma assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation. J Clin Microbiol 2001, 39:3938-3941.
13. Gimeno C., Solano C., Latorre J.C., et al. Quantification of DNA in plasma by an automated real-time PCR assay (CMV PCR Kit, Abbott) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol 2008, 46:3311-3318.
14. Emery V.C., Cope A.V., Bowen E.F., Gor D., Griffiths P.D. The dynamics of human cytomegalovirus replication in vivo. J Exp Med 1999, 177-182.
15. + T cells early after allogeneic stem cell transplantation may identify patients at risk of active CMV infection. Haematologica 2008, 93:1434-1436.
16. Kadakia M.P., Rybka W.B., Stewart J.A., et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood 1996, 87:5341-5344.
17. Wang F.Z., Dahl H., Linde A., Brytting M., Ehrnst A., Ljungman P. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996, 88:3615-3620.
18. Chan P.K.S., Peiris J.S.M., Yuen K.Y., et al. Human herpesvirus 6 and human herpesvirus 7 infections in bone marrow transplant recipients. J Med Virol 1997, 53:295-305.
19. Ljungman P., Wang F.Z., Clark D., et al. High levels of human herpesvirus 6 DNA in peripheral blood leukocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000, 111:774-781.
20. Imbert-Marcille B.M., Tang X.W., Lepelletier D., et al. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin Infect Dis 2000, 31:881-886.
21. Sashihara J., Tanaka-Taya K., Tanaka S., et al. High incidence of human herpesvirus infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002, 100:2005-2011.
22. Boutolleau D., Fernandez C., André E., et al. Human herpesvirus (HHV)-6 and HHV-7: 2 closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 2003, 187:179-186.
23. Volin L., Lautenschlager I., Juvonen E., Nihtinen A., Anttila V.-J., Ruutu T. Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other herpesviruses. Br J Haematol 2004, 126:690-696.
24. Hentrich M., Oruzio D., Jäger D., et al. Impact of human herpesvirus 6 after hematopoietic stem cell transplantation. Br J Haematol 2005, 128:66-72.
25. Ogata M., Kikuchi H., Satou T., et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and significance. J Infect Dis 2006, 193:68-79.
26. Wang L.R., Dong L.J., Zhang M.J., Lu D.P. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006, 12:1031-1037.
27. Cone R.W., Huang M.-L.W., Corey L., Zeh J., Ashley R., Bowden R. Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. J Infect Dis 1999, 179:311-318.
28. Gentile G., Capobianchi A., Ferraironi M., et al. Relationship of serum human herpesvirus DNA with cytomegalovirus pp65 antigenemia in allogeneic bone marrow transplant recipients. Transplantation 2004, 77:1907-1908.
29. Achour A., Boutolleau D., Gautheret-Dejean A., Agut H. Is human herpesvirus 6 DNA in plasma the right marker for active infection?. J Infect Dis 2006, 194:1795-1796.
30. Ward K.N., Leong H.N., Nacheva E.P., et al. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera and hair follicles. J Clin Microbiol 2006, 44:1571-1574.
31. Yamane A., Mori T., Suzuki T., et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007, 13:100-106.
32. Ogata M., Satou T., Kawano R., et al. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant 2008, 41:279-285.
33. Wang L.R., Dong L.J., Zhang M.J., Lu D.P. Correlations of humen herpesvirus 6B and CMV infection with acute GvHD in recipients of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 42:673-677.
34. De Bolle L., Naesens L., De Clercq E. Update on human herpesvirus 6 biology, clinical features and therapy. Clin Microbiol Rev 2005, 18:217-245.
35. Funk G.A., Gosert R., Hirsch H. Viral dynamics in transplant patients: implications for disease. Lancet Infect Dis 2007, 7:460-472.